← Leaderboards
Selna L Kaplan
University Of California San Francisco
$154,794
Attributed
$154,794
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$154,794 · 6
By mechanism
M01$154,794 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Stephen E Gitelman$12,344,642
- Stephen M Rosenthal$3,020,669
- Robert Mathias$25,799
- Michael W Dae$1,720,469
- Laurence Baskin$11,109,640
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationHuman SubjectClinical ResearchChild (0-11)Hormone TherapyDrug Screening /EvaluationEndocrine Disorder ChemotherapyGender DifferenceGonadotropin Releasing FactorHormone Regulation /Control MechanismHuman PubertyPrecocious PubertyPrognosisEndocrine Disorder DiagnosisEndocrine SurgeryFollicle Stimulating HormoneRelapse /RecurrenceSex Development DisorderGonadotropinsHormone AnalogHormone MetabolismSlow Release DrugBone Marrow TransplantationSomatotropin
Grant awards (30)
ENDOCRINE DYSFUNCTION AFTER BONE MARROW TRANSPLANT--CONCOMMITANT CHEMOTHERAPY$0
M01 · FY2002 · RR
EFFICACY OF TRANSSPHENOIDAL SURGERY FOR CUSHING'S DISEASE IN CHILDREN$0
M01 · FY2002 · RR
CHILDREN WITH GROWTH RETARDATION ASSOCIATED WITH BIOINACTIVE GROWTH HORMONE$0
M01 · FY2002 · RR
EVALUATION OF GONADOTROPIN SECRETION IN CHILDREN$0
M01 · FY2002 · RR
EFFICACY AND SAFETY OF LUPRON DEPOT--STERILE LEUPROLIDE ACETATE$0
M01 · FY2002 · RR
USE OF LRF AGONIST FOR TREATMENT OF PRECOCIOUS PUBERTY$0
M01 · FY2002 · RR
EFFICACY AND SAFETY OF LUPRON DEPOT--STERILE LEUPROLIDE ACETATE$0
M01 · FY2001 · RR
ENDOCRINE DYSFUNCTION AFTER BONE MARROW TRANSPLANT--CONCOMMITANT CHEMOTHERAPY$0
M01 · FY2001 · RR
USE OF LRF AGONIST FOR TREATMENT OF PRECOCIOUS PUBERTY$0
M01 · FY2001 · RR
EFFICACY OF TRANSSPHENOIDAL SURGERY FOR CUSHING'S DISEASE IN CHILDREN$0
M01 · FY2001 · RR
CHILDREN WITH GROWTH RETARDATION ASSOCIATED WITH BIOINACTIVE GROWTH HORMONE$0
M01 · FY2001 · RR
EVALUATION OF GONADOTROPIN SECRETION IN CHILDREN$0
M01 · FY2001 · RR
EFFICACY OF TRANSSPHENOIDAL SURGERY FOR CUSHING'S DISEASE IN CHILDREN$25,799
M01 · FY2000 · RR
CHILDREN WITH GROWTH RETARDATION ASSOCIATED WITH BIOINACTIVE GROWTH HORMONE$25,799
M01 · FY2000 · RR
USE OF LRF AGONIST FOR TREATMENT OF PRECOCIOUS PUBERTY$25,799
M01 · FY2000 · RR
ENDOCRINE DYSFUNCTION AFTER BONE MARROW TRANSPLANT--CONCOMMITANT CHEMOTHERAPY$25,799
M01 · FY2000 · RR
EFFICACY AND SAFETY OF LUPRON DEPOT--STERILE LEUPROLIDE ACETATE$25,799
M01 · FY2000 · RR
EVALUATION OF GONADOTROPIN SECRETION IN CHILDREN$25,799
M01 · FY2000 · RR
EFFICACY OF TRANSSPHENOIDAL SURGERY FOR CUSHING'S DISEASE IN CHILDREN$0
M01 · FY2000 · RR
EFFICACY OF TRANSSPHENOIDAL SURGERY FOR CUSHING'S DISEASE IN CHILDREN$0
M01 · FY2000 · RR
EFFICACY AND SAFETY OF LUPRON DEPOT--STERILE LEUPROLIDE ACETATE$0
M01 · FY2000 · RR
EFFICACY AND SAFETY OF LUPRON DEPOT--STERILE LEUPROLIDE ACETATE$0
M01 · FY2000 · RR
ENDOCRINE DYSFUNCTION AFTER BONE MARROW TRANSPLANT--CONCOMMITANT CHEMOTHERAPY$0
M01 · FY2000 · RR
ENDOCRINE DYSFUNCTION AFTER BONE MARROW TRANSPLANT--CONCOMMITANT CHEMOTHERAPY$0
M01 · FY2000 · RR
USE OF LRF AGONIST FOR TREATMENT OF PRECOCIOUS PUBERTY$0
M01 · FY2000 · RR
USE OF LRF AGONIST FOR TREATMENT OF PRECOCIOUS PUBERTY$0
M01 · FY2000 · RR
CHILDREN WITH GROWTH RETARDATION ASSOCIATED WITH BIOINACTIVE GROWTH HORMONE$0
M01 · FY2000 · RR
CHILDREN WITH GROWTH RETARDATION ASSOCIATED WITH BIOINACTIVE GROWTH HORMONE$0
M01 · FY2000 · RR
EVALUATION OF GONADOTROPIN SECRETION IN CHILDREN$0
M01 · FY2000 · RR
EVALUATION OF GONADOTROPIN SECRETION IN CHILDREN$0
M01 · FY2000 · RR